This Combo Improves Outcomes Over Tamoxifen in Early Breast Cancer

New drug combo offers improved disease-free survival in patients with hormone receptor (HR)-positive early breast cancer.

Source: CancerNetwork - November 7, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news